BofA analyst Michael Ryskin raised the firm’s price target on Agilent to $147 from $140 and keeps a Neutral rating on the shares. While the firm says it appreciates Agilent’s improved product mix and secular growth drivers, calling the quarterly report “a step in the right direction” after last quarter’s “big cut,” it also says the valuation appears fair given higher China exposure and limited visibility into a market rebound.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on A:
